• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

microbiome

Pharma & Human Health

4D pharma plc enters into clinical collaboration agreement with MSD

June 13, 2018 Staff Editor

4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of Live Biotherapeutic Products, today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) […]

Pharma & Human Health

Microbiome differences between urban and rural populations start soon after birth

June 6, 2018 Staff Editor

An analysis comparing the intestinal microbiomes of both infants and adults living in rural and urban areas of Nigeria has revealed that not only are there many differences in adults living in subsistence environments versus […]

Finance

Microbiotica Enters into Microbiome Collaboration with Genentech

June 6, 2018 Staff Editor

Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, […]

Pharma & Human Health

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

May 21, 2018 Staff Editor

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company has submitted, and the Medicines and Healthcare products Regulatory Agency (MHRA) has cleared, a Clinical Trial […]

Finance

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

May 16, 2018 Staff Editor

Thryve, providers of high quality microbiotics and microbiome testing, announced today it has secured $1.4 million in funding. Participating investment firms include PivotNorth Capital, Unilever Ventures, Darling Ventures, Candela Paramount, Abstract Ventures and Joyance Partners. […]

Finance

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

May 9, 2018 Staff Editor

Lodo Therapeutics Corporation, a drug discovery and development company focused on identifying and producing unique, bioactive natural products directly from the microbial DNA sequence information contained in soil, today announced that it has formed a […]

Pharma & Human Health

FDA Clears 4D Pharma’s IND Application for Blautix

May 9, 2018 Staff Editor

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, has today announced that the Company has submitted, and the U.S. Food and Drug Administration (FDA) has cleared, an Investigational New […]

Finance

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing

April 28, 2018 Staff Editor

A-Mansia Biotech S.A. (A-Mansia), the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. muciniphila) bacterium, today announces a €13 million first close of its Series A financing, […]

Finance

Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M

April 19, 2018 Staff Editor

Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced the final close of its Series B funding round at $15.9 million with participation by existing investors Cycle […]

Finance

Synlogic Announces Registered Direct Offering of Common Stock

April 6, 2018 Staff Editor

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has agreed to sell 3,280,000 shares of its common stock to a large mutual […]

Finance

Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)

April 5, 2018 Staff Editor

Osaka, Japan and Somerville, MA, April 5 2017 – Finch Therapeutics, a privately held microbiome engineering company, and Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), today announced a global collaboration agreement to jointly develop FIN-524. […]

Posts navigation

1 2 »

Microbiome-based Diagnostics & Biomarkers: Free Market Report

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Fecal transplant turns cancer immunotherapy non-responders into responders
    February 10, 2021
  • Why microbiota samples should be collected in all clinical trials?
    January 26, 2021
  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
  • First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes
    September 25, 2020

ACCESS THE DECEMBER 2020 ISSUE:

Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Lallemand Health Solutions
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter